Please ensure Javascript is enabled for purposes of website accessibility
Prosper Junior Bakiny

Prosper Junior Bakiny


A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.

Recent articles


Could Moderna Be a Millionaire-Maker Stock?

The success of Moderna's COVID-19 vaccine could be just the beginning.


Why Bionano Genomics Stock Popped Today

A Wall Street analyst's target-price hike may have had something to do with it.


Why Athira Pharma Stock Dropped Today

The clinical-stage biopharma company announced the pricing of a public stock offering.


Why Humanigen Stock Is Down Today

The company announced an important change to one of its ongoing clinical trials.


2 Pot Stocks That Could Turn $200,000 Into $1 Million in 10 Years

The cannabis industry has a bright future, and these two companies could be among its biggest winners.


Why Lexicon Pharmaceuticals Stock Is Down Today

A downgrade from an analyst might have something to do with it.


Why DBV Technologies Stock Popped Today

After hitting a major regulatory roadblock, DBV Technologies sees a path to approval for its leading candidate.


Is Novavax's Growth Story Over?

The next few weeks could be critical for the biotech's coronavirus vaccine prospects.


Why Organogenesis Holdings Stock Is Soaring Today

The company announced its preliminary fourth-quarter financial results.


Why ShockWave Medical Stock Jumped Today

No news is good news for this company.


Why Esperion Therapeutics Stock Is Falling Today

The company gave a sneak peek into its fourth-quarter financial results.


Why T2 Biosystems Stock Is Soaring Today

Investors are excited about the prospects of the company's COVID-19 diagnostic test.


2 Healthcare Stocks That Crushed the Market Last Year -- And Still Have Room to Grow

These two providers of diabetes-related products and services have yet to scratch the surface of their potential.


Why Mesoblast Stock Skyrocketed Today

The company announced positive results from a clinical trial.


Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?

Will the tortoise beat the hare once again?


2 Lessons Investors Learned From COVID

After a tumultuous 2020, these important investing principles should serve shareowners well in 2021 and beyond.


Why Neoleukin Therapeutics Stock Is Down Today

The company is experiencing regulatory headwinds.


Why Fulgent Genetics Stock Is Dropping Today

A Wall Street analyst downgraded the genetics testing provider.


Why ViewRay Stock Dropped Today

The company announced the pricing of a public offering of common stock.


Why Intellia Therapeutics Stock Is Soaring Today

Investors are looking forward to what could be a great year for the biotechnology company.